Anzeige
Mehr »
Login
Donnerstag, 13.08.2020 Börsentäglich über 12.000 News von 644 internationalen Medien
Neuer Wolfram-Player legt los! Jetzt einsteigen...
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0MXU2 ISIN: US00163U1060 Ticker-Symbol: AMU 
Stuttgart
12.08.20
17:18 Uhr
8,958 Euro
-0,142
-1,56 %
1-Jahres-Chart
AMAG PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
AMAG PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
8,9549,13412.08.
9,0269,10412.08.

Aktuelle News zur AMAG PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrAMAG Pharmaceuticals' (AMAG) Q2 Loss Narrower Than Expected3
06.08.AMAG PHARMACEUTICALS, INC. - 8-K, Current Report2
27.07.Palatin Tech puts end to Vyleesi license agreement with Amag Pharma137
AMAG PHARMACEUTICALS Aktie jetzt für 0€ handeln
27.07.Palatin Technologies Mutually Terminates License Agreement With AMAG Pharma For Vyleesi379WASHINGTON (dpa-AFX) - Palatin Technologies Inc. (PTN) said it has mutually terminated the January 2017 license agreement which granted AMAG Pharmaceuticals exclusive North American rights...
► Artikel lesen
27.07.AMAG Pharmaceuticals, Inc.: AMAG Pharmaceuticals Completes Divestment of Women's Health Assets9
23.07.AMAG signs European partner as they hunt cash to get their lead drug through the clinic5
23.07.AMAG PHARMACEUTICALS, INC. - 8-K, Current Report4
23.07.AMAG Pharmaceuticals and Norgine B.V. Enter Into Exclusive Licensing Agreement to Commercialize Ciraparantag in Europe, Australia and New Zealand161Agreement provides AMAG with $30 million upfront payment and eligibility to receive up to $260 million in development and commercial milestones in addition to sales royalties Collaboration...
► Artikel lesen
12.07.AMAG Pharmaceuticals, Inc.: AMAG Announces Presentation of Ciraparantag Data at the International Society on Thrombosis and Haemostasis10
06.07.Hedge Funds Still Kind Of Bullish On AMAG Pharmaceuticals, Inc. (AMAG)7
11.06.BRIEF-AMAG Pharmaceuticals Says Edward Myles, Chief Financial And Chief Operating Officer, Is Leaving Company12
11.06.AMAG Pharma's finance chief bids adieu7
11.06.AMAG PHARMACEUTICALS, INC. - 8-K, Current Report5
22.05.AMAG Pharma Sells Off Women's Health Product in Planned Divestment33
22.05.BRIEF-AMAG Pharmaceuticals Completes Sale Of Rights To Intrarosa To Millicent Pharma For Up To $125 Million15
21.05.AMAG Pharmaceuticals, Inc.: AMAG Pharmaceuticals Completes Sale of its Rights to Intrarosa to Millicent Pharma for up to $125 Million8
13.05.The new CEO at troubled AMAG begins his battle against an array of threats by axing staff and slashing costs12
12.05.AMAG Pharmaceuticals (AMAG) Reports Q1 Loss, Beats on Revenues10
12.05.AMAG Pharma Cuts 140 Jobs Amid Restructuring, COVID-19 Disruptions5
11.05.AMAG Pharmaceuticals: Shedding Lackadaisical Segments And Management - Becoming A Focused, Undervalued Pure Play5
Seite:  Weiter >>
43 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1